Selected research
Market Structure
Global Plant Derivative Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Plant Derivative Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Plant Derivative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Plant Derivative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plant Derivative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Plant Derivative Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Plant Derivative Drug include Yunnan Baiyao, Weleda, Tsumura, Tong Ren Tang, Tasly Holding Group, Taiji, Schwabe, Kwangdong and Jumpcan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Plant Derivative Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Plant Derivative Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plant Derivative Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Plant Derivative Drug market size, projected growth trends, production technologies, key applications, and end-use industries.
Plant Derivative Drug Segment by Company
Yunnan Baiyao
Weleda
Tsumura
Tong Ren Tang
Tasly Holding Group
Taiji
Schwabe
Kwangdong
Jumpcan Pharmaceutical
Huarun 999
GW Pharmaceuticals
Guangzhou Baiyunshan Pharmaceutical
China TCM
Buchang Pharmaceuticals
Bionorica Se
Plant Derivative Drug Segment by Type
Prescription Drug
OTC
Plant Derivative Drug Segment by Application
Tumor
Cardiovascular
Respiratory System
Other
Plant Derivative Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant Derivative Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plant Derivative Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant Derivative Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Plant Derivative Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plant Derivative Drug industry.
Chapter 3: Detailed analysis of Plant Derivative Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plant Derivative Drugrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription Drug
- OTC
Applications
- Tumor
- Cardiovascular
- Respiratory System
- Other
Companies covered
- Yunnan Baiyao
- Weleda
- Tsumura
- Tong Ren Tang
- Tasly Holding Group
- Taiji
- Schwabe
- Kwangdong
- Jumpcan Pharmaceutical
- Huarun 999
- GW Pharmaceuticals
- Guangzhou Baiyunshan Pharmaceutical
- China TCM
- Buchang Pharmaceuticals
- Bionorica Se
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Plant Derivative Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Prescription Drug
- 1.2.3 OTC
- 1.3 Market Analysis by Application
- 1.3.1 Global Plant Derivative Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Tumor
- 1.3.3 Cardiovascular
- 1.3.4 Respiratory System
- 1.3.5 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Plant Derivative Drug Growth Trends by Region
- 1.5.1 Global Plant Derivative Drug Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Plant Derivative Drug Market Size by Region (2021-2026)
- 1.5.3 Plant Derivative Drug Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Plant Derivative Drug Market Dynamics
- 2.1 Plant Derivative Drug Industry Trends
- 2.2 Plant Derivative Drug Industry Drivers
- 2.3 Plant Derivative Drug Industry Opportunities and Challenges
- 2.4 Plant Derivative Drug Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Plant Derivative Drug Revenue by Company (2021-2026)
- 3.2 Global Plant Derivative Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Plant Derivative Drug Key Company Head office and Area Served
- 3.4 Global Plant Derivative Drug Company, Product Type & Application
- 3.5 Global Plant Derivative Drug Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Plant Derivative Drug Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Plant Derivative Drug Players Market Share by Revenue in 2025
- 3.6.3 2025 Plant Derivative Drug Tier 1, Tier 2, and Tier 3
4 Plant Derivative Drug Market by Type
- 4.1 Global Plant Derivative Drug Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Plant Derivative Drug Market Size by Type (2021-2032)
- 4.3 Global Plant Derivative Drug Market Size Share by Type (2021-2032)
5 Plant Derivative Drug Market by Application
- 5.1 Global Plant Derivative Drug Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Plant Derivative Drug Market Size by Application (2021-2032)
- 5.3 Global Plant Derivative Drug Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Yunnan Baiyao
- 6.1.1 Yunnan Baiyao Company Information
- 6.1.2 Yunnan Baiyao Business Overview
- 6.1.3 Yunnan Baiyao Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Yunnan Baiyao Plant Derivative Drug Product Portfolio
- 6.1.5 Yunnan Baiyao Recent Developments
- 6.2 Weleda
- 6.2.1 Weleda Company Information
- 6.2.2 Weleda Business Overview
- 6.2.3 Weleda Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Weleda Plant Derivative Drug Product Portfolio
- 6.2.5 Weleda Recent Developments
- 6.3 Tsumura
- 6.3.1 Tsumura Company Information
- 6.3.2 Tsumura Business Overview
- 6.3.3 Tsumura Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Tsumura Plant Derivative Drug Product Portfolio
- 6.3.5 Tsumura Recent Developments
- 6.4 Tong Ren Tang
- 6.4.1 Tong Ren Tang Company Information
- 6.4.2 Tong Ren Tang Business Overview
- 6.4.3 Tong Ren Tang Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Tong Ren Tang Plant Derivative Drug Product Portfolio
- 6.4.5 Tong Ren Tang Recent Developments
- 6.5 Tasly Holding Group
- 6.5.1 Tasly Holding Group Company Information
- 6.5.2 Tasly Holding Group Business Overview
- 6.5.3 Tasly Holding Group Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Tasly Holding Group Plant Derivative Drug Product Portfolio
- 6.5.5 Tasly Holding Group Recent Developments
- 6.6 Taiji
- 6.6.1 Taiji Company Information
- 6.6.2 Taiji Business Overview
- 6.6.3 Taiji Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Taiji Plant Derivative Drug Product Portfolio
- 6.6.5 Taiji Recent Developments
- 6.7 Schwabe
- 6.7.1 Schwabe Company Information
- 6.7.2 Schwabe Business Overview
- 6.7.3 Schwabe Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Schwabe Plant Derivative Drug Product Portfolio
- 6.7.5 Schwabe Recent Developments
- 6.8 Kwangdong
- 6.8.1 Kwangdong Company Information
- 6.8.2 Kwangdong Business Overview
- 6.8.3 Kwangdong Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Kwangdong Plant Derivative Drug Product Portfolio
- 6.8.5 Kwangdong Recent Developments
- 6.9 Jumpcan Pharmaceutical
- 6.9.1 Jumpcan Pharmaceutical Company Information
- 6.9.2 Jumpcan Pharmaceutical Business Overview
- 6.9.3 Jumpcan Pharmaceutical Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Jumpcan Pharmaceutical Plant Derivative Drug Product Portfolio
- 6.9.5 Jumpcan Pharmaceutical Recent Developments
- 6.10 Huarun 999
- 6.10.1 Huarun 999 Company Information
- 6.10.2 Huarun 999 Business Overview
- 6.10.3 Huarun 999 Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Huarun 999 Plant Derivative Drug Product Portfolio
- 6.10.5 Huarun 999 Recent Developments
- 6.11 GW Pharmaceuticals
- 6.11.1 GW Pharmaceuticals Company Information
- 6.11.2 GW Pharmaceuticals Business Overview
- 6.11.3 GW Pharmaceuticals Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 GW Pharmaceuticals Plant Derivative Drug Product Portfolio
- 6.11.5 GW Pharmaceuticals Recent Developments
- 6.12 Guangzhou Baiyunshan Pharmaceutical
- 6.12.1 Guangzhou Baiyunshan Pharmaceutical Company Information
- 6.12.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
- 6.12.3 Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Product Portfolio
- 6.12.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
- 6.13 China TCM
- 6.13.1 China TCM Company Information
- 6.13.2 China TCM Business Overview
- 6.13.3 China TCM Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 China TCM Plant Derivative Drug Product Portfolio
- 6.13.5 China TCM Recent Developments
- 6.14 Buchang Pharmaceuticals
- 6.14.1 Buchang Pharmaceuticals Company Information
- 6.14.2 Buchang Pharmaceuticals Business Overview
- 6.14.3 Buchang Pharmaceuticals Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Buchang Pharmaceuticals Plant Derivative Drug Product Portfolio
- 6.14.5 Buchang Pharmaceuticals Recent Developments
- 6.15 Bionorica Se
- 6.15.1 Bionorica Se Company Information
- 6.15.2 Bionorica Se Business Overview
- 6.15.3 Bionorica Se Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Bionorica Se Plant Derivative Drug Product Portfolio
- 6.15.5 Bionorica Se Recent Developments
7 North America
- 7.1 North America Plant Derivative Drug Market Size (2021-2032)
- 7.2 North America Plant Derivative Drug Market Size by Type
- 7.2.1 North America Plant Derivative Drug Market Size by Type (2021-2026)
- 7.2.2 North America Plant Derivative Drug Market Size by Type (2027-2032)
- 7.2.3 North America Plant Derivative Drug Market Share by Type (2021-2032)
- 7.3 North America Plant Derivative Drug Market Size by Application
- 7.3.1 North America Plant Derivative Drug Market Size by Application (2021-2026)
- 7.3.2 North America Plant Derivative Drug Market Size by Application (2027-2032)
- 7.3.3 North America Plant Derivative Drug Market Share by Application (2021-2032)
- 7.4 North America Plant Derivative Drug Market Size by Country
- 7.4.1 North America Plant Derivative Drug Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Plant Derivative Drug Market Size by Country (2021-2026)
- 7.4.3 North America Plant Derivative Drug Market Size by Country (2027-2032)
- 7.4.4 North America Plant Derivative Drug Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Plant Derivative Drug Market Size (2021-2032)
- 8.2 Europe Plant Derivative Drug Market Size by Type
- 8.2.1 Europe Plant Derivative Drug Market Size by Type (2021-2026)
- 8.2.2 Europe Plant Derivative Drug Market Size by Type (2027-2032)
- 8.2.3 Europe Plant Derivative Drug Market Share by Type (2021-2032)
- 8.3 Europe Plant Derivative Drug Market Size by Application
- 8.3.1 Europe Plant Derivative Drug Market Size by Application (2021-2026)
- 8.3.2 Europe Plant Derivative Drug Market Size by Application (2027-2032)
- 8.3.3 Europe Plant Derivative Drug Market Share by Application (2021-2032)
- 8.4 Europe Plant Derivative Drug Market Size by Country
- 8.4.1 Europe Plant Derivative Drug Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Plant Derivative Drug Market Size by Country (2021-2026)
- 8.4.3 Europe Plant Derivative Drug Market Size by Country (2027-2032)
- 8.4.4 Europe Plant Derivative Drug Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Plant Derivative Drug Market Size (2021-2032)
- 9.2 China Plant Derivative Drug Market Size by Type
- 9.2.1 China Plant Derivative Drug Market Size by Type (2021-2026)
- 9.2.2 China Plant Derivative Drug Market Size by Type (2027-2032)
- 9.2.3 China Plant Derivative Drug Market Share by Type (2021-2032)
- 9.3 China Plant Derivative Drug Market Size by Application
- 9.3.1 China Plant Derivative Drug Market Size by Application (2021-2026)
- 9.3.2 China Plant Derivative Drug Market Size by Application (2027-2032)
- 9.3.3 China Plant Derivative Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Plant Derivative Drug Market Size (2021-2032)
- 10.2 Asia Plant Derivative Drug Market Size by Type
- 10.2.1 Asia Plant Derivative Drug Market Size by Type (2021-2026)
- 10.2.2 Asia Plant Derivative Drug Market Size by Type (2027-2032)
- 10.2.3 Asia Plant Derivative Drug Market Share by Type (2021-2032)
- 10.3 Asia Plant Derivative Drug Market Size by Application
- 10.3.1 Asia Plant Derivative Drug Market Size by Application (2021-2026)
- 10.3.2 Asia Plant Derivative Drug Market Size by Application (2027-2032)
- 10.3.3 Asia Plant Derivative Drug Market Share by Application (2021-2032)
- 10.4 Asia Plant Derivative Drug Market Size by Country
- 10.4.1 Asia Plant Derivative Drug Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Plant Derivative Drug Market Size by Country (2021-2026)
- 10.4.3 Asia Plant Derivative Drug Market Size by Country (2027-2032)
- 10.4.4 Asia Plant Derivative Drug Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Plant Derivative Drug Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Plant Derivative Drug Market Size by Type
- 11.2.1 South America, Middle East & Africa Plant Derivative Drug Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Plant Derivative Drug Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Plant Derivative Drug Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Plant Derivative Drug Market Size by Application
- 11.3.1 South America, Middle East & Africa Plant Derivative Drug Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Plant Derivative Drug Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Plant Derivative Drug Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Plant Derivative Drug Market Size by Country
- 11.4.1 South America, Middle East & Africa Plant Derivative Drug Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Plant Derivative Drug Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Plant Derivative Drug Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Plant Derivative Drug Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst